Grant Programs Supporting Testing of Agents Against Biowarfare

AGENCY: BARDA

ANNOUNCEMENT: CBRN-BAA-13-100-SOL-00013

SUBMISSION: ROLLING

AWARD: UNCAPPED

COMMENTS: Various areas of interest, however they are specifically asking for “Antitoxins and Therapeutics”: large or small molecules with formulations offering long-term stability or antibody treatments and other biologics for viral hemorrhagic fevers viruses.

 AGENCY: DTRA

ANNOUNCEMENT: HDTRA1-14-CHEM-BIO-BAA

SUBMISSION: Dec. 22 (Phase I – White Paper); Mar 12 (Phase II – Full Application)

AWARD: UNCAPPED

COMMENTS: Topic 1 (CBM-02): platform technologies for rapid and translational vaccine designs with IND within 5 years; Topic 2 (CBM-05): Novel medical countermeasures development targeting filoviradae pathogens and resistance; for Marburg or Ebola and any combo of the five Ebola virus species.

 

ANNOUNCMENT: HDTRA1-15-EBOLA-BAA (W81XWH-BAA-15-1)

SUBMISSION: ROLLING

AWARD: UNCAPPED

COMMENTS: Development of near term solutions, such as therapeutic and vaccine candidates; for medical countermeasures-only late stage development products for EBOV than can be completed in the near term are considered (in time to assist the current EBOV outbreak)!

 

AGENCY: NIAID

ANNOUNCEMENT: NIAID R34

SUBMISSION: Jan. 13, 2015

AWARD: $150,000

COMMENTS: $150,000/ year for 1 year; clinical trial planning grant

 

ANNOUNCEMENT: NIAID U01

SUBMISSION: Jan. 13, 2015

AWARD: $2.5M

COMMENTS: $500,000/ year up to 5 years; high risk clinical trials, IND required

 

ANNOUNCEMENT: BAA-EBOLA-2014

SUBMISSION: ROLLING

AWARD: $100,000-$1M

COMMENTS: Support development of practical and cost-effective innovations that help healthcare workers on front lines better care and stop the spread of Ebola; preclinical or clinical.  See pages 9-10 of BAA to learn what they are looking for and not looking for.

 

AGENCY: NIBIB-Multi-Institutional

ANNOUNCMENT: R21-PAR-12-284

SUBMISSION: Feb. 16, 2015

AWARD: $275,000

COMMENTS: $275,000 over 2 years, no more than $200,000/ year; exploratory development bioengineering research grants (EBRG) establish feasibility of technologies that explore a unique multi-disciplinary approach, are high-risk but have a considerable payoff; develop data which can lead to significant future research; hypothesis driven to evaluate unproven approaches for which there is minimal or no preliminary data.

 

ANNOUNCEMENT: PAR-14-092

SUBMISSION: May 20, 2015; Sept. 18, 2015

AWARD: $2.5M

COMMENTS: $500,000/ year up to 5 years; accelerate development of promising technologies; unmet needs; solution within 5-10 years

 

AGENCY: NIH

ANNOUNCMENT: R21-PA-13-303

SUBMISSION: Feb 5; June 5. Oct. 5 (each year)

AWARD: $385,000

COMMENTS: $275,000 direct costs up to 2 years + 40% indirects =$385,000

 

ANNOUNCMENT: R01-PA-13-302

SUBMISSION: Feb 16; June 16; Oct 16 (each year)

AWARD: $3,500,000

COMMENTS: $500K direct costs per year up to 5 years + 40% indirect costs = $3.5M

  

AGENCY: USAMRMC

ANNOUNCEMENT: USAMRMC-BAA-15-1

SUBMISSION: ROLLING

AWARD: UNCAPPED

COMMENTS: Uncapped budget must reflect scope for up to 5 years; provide solution to medical problems of importance to the American warfighter; medical biological defense